ArticleOncoimmunology2026

Targeting tumor-selective membrane-associated PCNA enables selective antibody-drug conjugate therapy.

Muhammad Abu Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.